Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE: PRO)

Morocco flag Morocco · Delayed Price · Currency is MAD
873.00
-47.00 (-5.11%)
At close: Nov 13, 2024
-7.32%
Market Cap 920.00M
Revenue (ttm) 805.52M
Net Income (ttm) 56.90M
Shares Out 1.00M
EPS (ttm) 56.90
PE Ratio 16.17
Forward PE n/a
Dividend 40.00 (4.58%)
Ex-Dividend Date n/a
Volume 90
Open 873.00
Previous Close 920.00
Day's Range 873.00 - 873.00
52-Week Range 873.00 - 1,150.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Dec 27, 2024

About PRO

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco. Societe de Promotion Pharmaceutique du Maghreb S.A. operates as a subsidiary of Hikma Pharmaceuticals PLC. [Read more]

Industry Pharmaceutical Preparations
Founded 1947
Employees 343
Stock Exchange Casablanca Stock Exchange
Ticker Symbol PRO
Full Company Profile

Financial Performance

In 2023, PRO's revenue was 805.52 million, an increase of 14.32% compared to the previous year's 704.64 million. Earnings were 56.90 million, a decrease of -24.42%.

Financial Statements

News

There is no news available yet.